Differential expression of RBM5 and KRAS in pancreatic ductal adenocarcinoma and their association with clinicopathological features

By Peng Jie   Valeshabad Ali Kord   Li Qingfu   Wang Yuan  

Oncology Letters, Vol. 5, Iss. 3, 2013-03 ,pp. : 1000-1004

Spandidos Publications

Access to resources Recommend Favorite

Differential Expression of Cytochrome P450 Omega-hydroxylase Isoforms and Their Association with Clinicopathological Features in Pancreatic Ductal Adenocarcinoma

By Gandhi Ankit   Saxena Shivam   Relles Daniel   Sarosiek Konrad   Kang Christopher   Chipitsyna Galina   Andrel Sendecki Jocelyn   Yeo Charles   Arafat Hwyda  

Annals of Surgical Oncology, Vol. 20, Iss. 3, 2013-12 ,pp. : 636-643

Springer Publishing Company

Access to resources Recommend Favorite

High Expression of Interleukin-22 and Its Receptor Predicts Poor Prognosis in Pancreatic Ductal Adenocarcinoma

By Wen Zhang   Liao Quan   Zhao Jianguo   Hu Ya   You Lei   Lu Zhaohui   Jia Congwei   Wei Yingxin   Zhao Yupei  

Annals of Surgical Oncology, Vol. 21, Iss. 1, 2014-01 ,pp. : 125-132

Springer Publishing Company

Access to resources Recommend Favorite

Role of thymidine phosphorylase and orotate phosphoribosyltransferase mRNA expression and its ratio to dihydropyrimidine dehydrogenase in the prognosis and clinicopathological features of patients with pancreatic cancer

By Miyake Kotaro   Imura Satoru   Yoshizumi Tomoharu   Ikemoto Tetsuya   Morine Yuji   Shimada Mitsuo  

International Journal of Clinical Oncology, Vol. 12, Iss. 2, 2007-04 ,pp. : 111-119

Springer Publishing Company

Access to resources Recommend Favorite

Heparanase regulates in vitro VEGF-C expression and its clinical significance to pancreatic ductal cell adenocarcinoma

By        

Oncology Letters, Vol. 11, Iss. 2, 2016-01 ,pp. : 1327-1334

Spandidos Publications

Access to resources Recommend Favorite